18F-FAPI PET/MRI Imaging in Myelofibrosis: a Prospective Observational Study.

Sponsor
First Affiliated Hospital of Zhejiang University
Study ID
NCT06164561
Status
Recruiting
Apply to this trial

Conditions

  • Myelofibrosis

Eligibility Criteria

Sex
ALL
Age
18 Years - 80 Years
Healthy Volunteers
Not accepted

Study Details

This study intends to use a prospective, observational, self-controlled, multi-center study design to evaluate the feasibility and diagnostic efficacy of 18F-FDG PET/CT and 18F-FAPI PET/MRI imaging for the evaluation of systemic fibrosis in MF patients based on the results of bone marrow pathological biopsy, and to analyze the relationship between imaging results and clinical prognosis.

Key Dates

First listed
Dec 11, 2023
Start date
Nov 21, 2023
Status verified
Feb 2025
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
57 participants (estimated)

Primary Outcome Measure

The diagnostic efficiency of 18F-FAPI PET/MRI imaging in myelofibrosis [ Time Frame: through study completion, an average of 2 years ]

Central Contacts

Related Studies